GWPH Stock Price - GW Pharmaceuticals PLC ADR Stock Quote (U.S.: Nasdaq) - MarketWatch

Horrell Capital Management, Inc. Buys NetScout Systems Inc, MicroStrategy Inc, Juniper Networks Inc, Sells Team Inc, LM Ericsson Telephone Co, Deltic Timber Corp

Apr. 11, 2018 at 1:38 p.m. ET
on GuruFocus.com

The 10 Largest Marijuana Stocks

Apr. 9, 2018 at 8:21 a.m. ET
on Motley Fool

Marijuana Stock Charts: How 3 Pot Plays Performed in Volatile Markets

A series of headlines out of Canada caused a unique selloff in that country's budding marijuana market. With this in mind, let's take a closer look at how a few popular stocks with exposure to the marijuana industry fared during this recent volatility.

Apr. 6, 2018 at 5:41 p.m. ET
on Zacks.com

Institutional Top Ideas Series: Broadfin Capital

Apr. 5, 2018 at 12:11 p.m. ET
on Seeking Alpha

Here’s Why The Mayo Clinic Owns 10% of This Unknown Epilepsy Stock with Big Upcoming FDA Catalyst

- About 1/3 of epilepsy patients fail to respond to drugs, and many of these patients are eligible for ...

Apr. 4, 2018 at 7:31 a.m. ET
on Baystreet.ca

GW Pharma's Cannabinoid-Based Epilepsy Position Continues To Strengthen

Apr. 2, 2018 at 11:58 a.m. ET
on Seeking Alpha

Baker Bros. Advisors Lp Buys Biomarin Pharmaceutical Inc, Ablynx NV, Erytech Pharma, Sells ...

Baker Bros. Advisors Lp Buys Biomarin Pharmaceutical Inc, Ablynx NV, Erytech Pharma, Sells Advanced Accelerator Applications SA, Achaogen Inc, NeuroDerm

Mar. 29, 2018 at 6:38 p.m. ET
on GuruFocus.com

Revolutionary Cannabinoid Prodrug Goes Global with International Patent Prosecution

A new form of cannabinoid prodrugs called “cannabosides”, which were discovered using innovative ...

Mar. 28, 2018 at 9:22 a.m. ET
on Baystreet.ca

3 Biotechs That Could Get Big Boosts in April

Mar. 28, 2018 at 6:04 a.m. ET
on Motley Fool

The Time To Buy Things Is When They're On Sale!

Mar. 26, 2018 at 5:05 p.m. ET
on Seeking Alpha

3 Blockbuster Drug Launches to Watch In 2018

Mar. 26, 2018 at 7:47 a.m. ET
on Motley Fool

Factors of Influence in 2018, Key Indicators and Opportunity within Magic Software Enterprises, Tuniu, Visteon, Magna International, Eaton Corporation, and GW Pharmaceuticals -- New Research Emphasizes Economic Growth

Factors of Influence in 2018, Key Indicators and Opportunity within Magic Software Enterprises, Tuniu, Visteon, Magna International, Eaton Corporation, and GW Pharmaceuticals -- New Research Emphasizes Economic Growth

Apr. 12, 2018 at 7:30 a.m. ET
on GlobeNewswire

GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on Epidiolex(R) (cannabidiol oral solution) at the 2018 American Academy of Neurology Annual Meeting

Apr. 12, 2018 at 7:00 a.m. ET
on GlobeNewswire

Celebrities Dipping Into the CBD Market

Apr. 11, 2018 at 1:30 p.m. ET
on PR Newswire - PRF

Cannabis Product Sales are Expected to Increase as Legalization Continues to Expand

Apr. 5, 2018 at 9:40 a.m. ET
on PR Newswire - PRF

Companies That Stand to Benefit From Record Growth in CBD Market

Apr. 4, 2018 at 10:00 a.m. ET
on PR Newswire - PRF

Here's Why The Mayo Clinic Owns 10% of This Unknown Epilepsy Stock with Big Upcoming FDA Catalyst

Apr. 4, 2018 at 7:33 a.m. ET
on ACCESSWIRE

Infusion of Biotechnology Into Cannabis Market Leads to Booming Growth

Apr. 3, 2018 at 8:30 a.m. ET
on PR Newswire - PRF

Medical and Legal Cannabis Markets are Projected to Increase in Value

Mar. 23, 2018 at 9:00 a.m. ET
on PR Newswire - PRF

Ontario Moves Ahead With Plan to License Cannabis Lounges

Mar. 21, 2018 at 9:00 a.m. ET
on PR Newswire - PRF

Report: Developing Opportunities within Capital Product Partners, Adient, Arbutus Biopharma, GW Pharmaceuticals, Customers, and Laureate Education -- Future Expectations, Projections Moving into 2018

Mar. 16, 2018 at 8:20 a.m. ET
on GlobeNewswire

GW Pharmaceuticals Announces Receipt of Notices of Allowance by the United States Patent and Trademark Office (USPTO) for Five New Epidiolex(R) (cannabidiol) Patents

Mar. 13, 2018 at 4:02 p.m. ET
on GlobeNewswire

Data Shows that the Global Legal Cannabis Market is Set to Increase in Value

Mar. 13, 2018 at 10:50 a.m. ET
on PR Newswire - PRF

Data Shows that Medical Cannabis Sales are set to Rise

Mar. 9, 2018 at 9:00 a.m. ET
on PR Newswire - PRF

GW Pharmaceuticals to Present at the Cowen and Company 38th Annual Health Care Conference on 12 March

Mar. 5, 2018 at 12:36 p.m. ET
on GlobeNewswire

Top CBD Companies to Capitalize, Should the Hoosier State Legalize Cannabidiol Oil

Mar. 2, 2018 at 10:30 a.m. ET
on PR Newswire - PRF

The Growth of Cannabis Legalization Across North America

Mar. 1, 2018 at 9:40 a.m. ET
on PR Newswire - PRF

Pre-Market Technical Scan on Drug Makers Equities -- GW Pharma, Heron Therapeutics, Immune Pharma, and Johnson & Johnson

Feb. 28, 2018 at 7:05 a.m. ET
on PR Newswire - PRF

GW Pharmaceuticals Receives Orphan Drug Designation from the European Medicines Agency (EMA) for Cannabidiol for the Treatment of Tuberous Sclerosis

Feb. 27, 2018 at 7:01 a.m. ET
on GlobeNewswire

India Globalization Advances Pre-Clinical Studies & CAM Products -- CFN Media

Feb. 26, 2018 at 8:30 a.m. ET
on GlobeNewswire

Medical and Recreational Cannabis Sales are on the Rise

Feb. 23, 2018 at 9:00 a.m. ET
on PR Newswire - PRF

GW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics from proprietary cannabinoid product platform in a broad range of disease areas. It operates through the following segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. The Commercial segment distributes and sells the commercial products and promotes Sativex through collaborations with pharmaceutical companies for the currently approved indication of spasticity due to multiple sclerosis. The Sativex Research and Development segment seeks to maximize the potential of Sativex through the development of new indications. The Pipeline Research and Development segment seeks to develop cannabinoid medications other than Sativex, which are using the proprietary cannabinoid technology platform. The company was founded by Geoffrey W. Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom. (See Full Profile)

Sell
Under
Hold
Over
Buy

Number of Ratings 6 Full Ratings

Name	Chg %	Market Cap
Novartis AG ADR	0.59%	$212.13B
Vernalis PLC ADR	-15.65%	$27.56M
Abcam PLC ADR	-2.16%	$3.78B
Insys Therapeutics Inc.	7.18%	$462.5M

Competitor Data Provided By

Dow	24,826.55	253.51	1.03%
S&P 500	2,705.44	27.60	1.03%
Nasdaq	7,269.15	112.87	1.58%
GlobalDow	3,085.49	17.39	0.57%
Gold	1,346.90	-3.80	-0.28%
Oil	66.09	-0.13	-0.20%

GW Pharmaceuticals PLC ADR

$ 131.39

Customize MarketWatch

No Items in Watchlist

No Saved Watchlists

Uh oh

No Recent Tickers

Stocks

Columns

Authors

Topics

^$ 131.39